Is my partner on a GLP-1? An observation quiz.
Ten questions about what you have actually noticed, followed by a conversation guide built on patient-provider communication research. The goal is not to catch anyone. It is to stop guessing and start talking.
Reviewed by the FormBlends Medical Review Team. Last reviewed .
Why partners often do not say anything first
The most common reason a partner does not mention a new prescription is not secrecy for its own sake. It is cost anxiety. GLP-1 medications are expensive, coverage is uneven, and people want to know the plan is working before announcing it. A 2024 JAMA Internal Medicine review of obesity-treatment disclosure by Puhl and colleagues found that patients delayed telling family members for weeks or months, and stigma was the strongest predictor of that delay.
The second reason is a pattern well-documented in patient-provider communication research: people rehearse a new treatment privately before sharing it, so they can answer the predictable questions. A 2022 Patient Education and Counseling paper on medication non-disclosure (Vermeir et al.) put it simply. Patients tell loved ones when they feel ready to defend the decision, not before.
Third, history matters. If weight has ever been a loaded topic in the relationship, even affectionately, the bar for bringing it up rises. Past diet failures, family commentary, and old injuries around body size all push the conversation later.
None of this is a character flaw. It is a reasonable response to real-world judgment. Your job, if you suspect a partner is on a GLP-1, is not to unmask them. It is to make the conversation safer than silence.
Have their portion sizes noticeably decreased?
They leave food on the plate more often, order appetizers instead of entrees, or seem satisfied with less than they used to eat.
How to actually have the conversation
A good opener does three things. It names something specific you have observed, it gives the other person room to respond without performing, and it leaves space for silence.
Try: "I have noticed you have been eating less and seem more at ease around food. I am not pushing for anything, but if something is going on, I am here." That is it. One observation, one offer, one door left open.
Do not lead with a theory. If you start with "Are you on Ozempic?" you have already answered your own question in their head, and the rest of the conversation becomes defense. A 2023 Health Communication paper by Ford and colleagues on stigmatized health disclosure showed that open-ended openers produced disclosure roughly twice as often as direct accusations.
Pick the setting carefully. Not bedtime. Not right after a fight. Not during a meal where food is the subject. A walk, a drive, a quiet evening on the couch. Environments with shared motion or shared silence lower the stakes.
If they are not ready, accept it. The worst outcome is not temporary silence. It is a partner who decides you are not a safe person to tell the truth to. Patience is strategic, not passive.
If they confirm they are on a GLP-1, your first line matters. "Thanks for telling me" beats "I knew it." Ask how they are feeling, how the side effects are going, whether the cost is sustainable, and whether they want company at an appointment. Be the partner you would want if the roles were reversed.
If they deny it and you still suspect something, drop it for now. A single conversation is not the whole relationship. You can revisit it later with more information. What you cannot do is force a disclosure. Trying will cost you more than waiting would.
Frequently asked questions
Is this quiz medically reliable?
No. It is an observational guide, not a diagnostic tool. The questions reflect common patterns described in clinical reports, but no quiz can confirm medication use. Only a conversation with your partner or their prescriber can do that. Treat the result as a prompt for a careful talk, never as proof.
What if I am wrong about what I think I am seeing?
You might be, and that is fine. Weight and appetite shift for many reasons, including stress, sleep changes, thyroid issues, depression, new medications, or just a new routine. A calm conversation that starts with what you have noticed, not what you have concluded, leaves room for a different answer. Humility protects the relationship.
Should I confront my partner about this?
Confrontation rarely works. The research on disclosure of stigmatized medications, including mental health and obesity treatments, consistently shows that accusatory framing pushes people further into secrecy. A low-stakes opener (I have noticed X, are you doing okay?) preserves trust and gives them room to share when ready. Patience tends to work better than interrogation.
Why would someone keep a GLP-1 prescription private?
Most often: cost anxiety, fear of judgment, wanting to see early results before raising the topic, or bruises from past weight-loss conversations. A 2024 JAMA Internal Medicine analysis of obesity-treatment disclosure found that stigma was the single strongest predictor of silence. The silence is usually about shame, not deceit.
Are GLP-1 medications safe?
The large clinical trials (STEP 1, SURMOUNT-1, SELECT) show an acceptable safety profile under medical supervision, with nausea, constipation, and early appetite changes as the most common side effects. Rare serious events include pancreatitis and gallbladder issues. Safety depends on proper screening, dosing, and follow-up, which is why every prescription should come through a licensed provider.
What should I do with my quiz result?
Read the conversation guide below the result. Pick one line that sounds like you, not a script. Choose a calm moment (not bedtime, not post-argument). Start with care, keep it short, and then listen. The quiz is a starting point, not a verdict.
Related reading
Zepbound Coupon 2026: How the Lilly Savings Card Works, Who Qualifies, and What You'll Actually Pay
The 2026 Zepbound coupon (Lilly Savings Card) reduces copays for eligible commercial-insurance patients. Eligibility, real prices, and alternatives if you don't qualify.
Mounjaro Coupon 2026: How the Lilly Savings Card Works for Diabetes Patients
The 2026 Mounjaro Savings Card from Lilly reduces copays for eligible commercial-insurance diabetes patients. Eligibility, real prices, and what to do if you don't qualify.
Wegovy Coupon in 2026: How the Savings Card Works, Who Qualifies, and What You'll Pay
How the Wegovy savings card works in 2026, who qualifies for $0 to $225 per month, and what to do if you're not eligible.
Zepbound Savings Card 2026: How It Works, Who Qualifies, and What You'll Pay
How the Zepbound savings card from Eli Lilly works in 2026, who pays $25 per month, who pays $550, and what to do if you're not eligible.
Ozempic Coupon in 2026: How the Savings Card Works, Who Qualifies, and What You'll Pay
How the Ozempic savings card from Novo Nordisk works in 2026, who pays as little as $25 per month, and the cheaper paths if you don't qualify.
Thinking about this for yourself?
If the quiz stirred something up about your own goals, we can help you get a medical consult without the sales pitch.
Start a free assessmentThis content is for informational and educational use only. It does not diagnose or confirm anyone's medication use and is not a substitute for professional medical advice. GLP-1 receptor agonist medications are prescription drugs that require physician supervision. If you have concerns about your own health or your partner's, speak with a licensed provider. Individual results and experiences vary.